We are live on
!
Find out more
OAM
Origin Asset Management Portfolio holdings
AUM
$43.5M
1-Year Est. Return
31.63%
This Fund
S&P 500
This Quarter
Est. Return
-6.81%
1 Year Est. Return
+31.63%
3 Year Est. Return
+59.29%
5 Year Est. Return
+154.06%
10 Year Est. Return
+689.27%
AUM
$1.21B
AUM Growth
-$168M
(-12%)
Cap. Flow
-$48.4M
Cap. Flow
% of AUM
-4.01%
Top 10 Holdings %
Top 10 Hldgs %
32.32%
Holding
123
New
22
Increased
12
Reduced
47
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dr. Reddy's Laboratories
RDY
|
+$37.1M |
| 2 |
Cognizant
CTSH
|
+$30.6M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$20.8M |
| 4 |
Universal Health Services
UHS
|
+$16.7M |
| 5 |
HCA Healthcare
HCA
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$32.5M |
| 2 |
Lincoln National
LNC
|
+$21M |
| 3 |
TSMC
TSM
|
+$19.9M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
+$16.5M |
| 5 |
Blackrock
BLK
|
+$15.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.69% |
| 2 | Healthcare | 20.85% |
| 3 | Financials | 15.03% |
| 4 | Industrials | 12.24% |
| 5 | Consumer Discretionary | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cognizant
CTSH
$21.2B
| $62M | 5.14% |
990,422
+487,475
| +97% | +$30.6M |
|
2
NetEase
NTES
$84.1B
| $49.7M | 4.11% |
2,066,705
-338,425
| -14% | -$8.72M |
|
|
3
TSMC
TSM
$2.07T
| $46.9M | 3.89% |
2,261,580
-949,300
| -30% | -$19.9M |
|
4
Apple
AAPL
$4.9T
| $43.3M | 3.59% |
1,569,228
+87,316
| +6% | +$2.56M |
|
|
5
Dr. Reddy's Laboratories
RDY
$10.5B
| $38.2M | 3.16% |
+2,987,340
| New | +$37.1M |
|
6
Lear
LEA
$7.1B
| $34M | 2.82% |
312,727
+23,696
| +8% | +$2.47M |
|
7
Snap-on
SNA
$21.3B
| $31M | 2.57% |
205,104
-7,109
| -3% | -$1.14M |
|
|
FL
8
DELISTED
Foot Locker
FL
| $29.1M | 2.41% |
404,644
-62,656
| -13% | -$4.46M |
|
9
Gilead Sciences
GILD
$167B
| $28.6M | 2.37% |
291,542
-12,887
| -4% | -$1.43M |
|
10
General Dynamics
GD
$99.7B
| $27.3M | 2.26% |
197,594
+52,172
| +36% | +$7.55M |
|
11
Marathon Petroleum
MPC
$91.3B
| $25.6M | 2.12% |
553,016
+149,116
| +37% | +$7.67M |
|
12
Goldman Sachs
GS
$314B
| $25.4M | 2.11% |
146,350
-24,849
| -15% | -$4.87M |
|
|
AET
13
DELISTED
Aetna Inc
AET
| $25.2M | 2.09% |
230,466
-39,161
| -15% | -$4.52M |
|
14
Cigna
CI
$74.5B
| $24.9M | 2.07% |
184,674
-95,444
| -34% | -$13.9M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $22.1M | 1.83% |
204,339
-9,498
| -4% | -$1.18M |
|
|
16
HCA Healthcare
HCA
$82.3B
| $21.1M | 1.75% |
272,708
+162,471
| +147% | +$14.4M |
|
17
CVS Health
CVS
$137B
| $20.9M | 1.73% |
216,518
-5,989
| -3% | -$630K |
|
18
Jones Lang LaSalle
JLL
$15.3B
| $20.8M | 1.73% |
144,896
+1,016
| +0.7% | +$166K |
|
19
Moody's
MCO
$89.2B
| $20.5M | 1.7% |
208,457
-8,180
| -4% | -$870K |
|
20
Wells Fargo
WFC
$265B
| $20.1M | 1.66% |
390,803
-13,630
| -3% | -$750K |
|
21
Aon
AON
$78.4B
| $18.6M | 1.54% |
210,189
-6,640
| -3% | -$643K |
|
|
22
Regeneron Pharmaceuticals
REGN
$70.9B
| $18M | 1.49% |
+38,775
| New | +$20.8M |
|
23
Broadcom
AVGO
$1.76T
| $16.5M | 1.37% |
1,319,980
-46,880
| -3% | -$592K |
|
24
Valero Energy
VLO
$91.9B
| $15.8M | 1.31% |
263,285
+178,647
| +211% | +$11.3M |
|
25
F5
FFIV
$23.1B
| $15.7M | 1.3% |
135,461
-8,536
| -6% | -$1.05M |
|
Similar funds
MC
SGL
CIA
VCM
VFA
CGI
AIM
SFM
Origin Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Origin Asset Management held 123 positions worth $1.21B, down 12% from $1.37B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Origin Asset Management withdrew a net $48.4M in Q3 2015, closing 24 positions and reducing 47 holdings. Its most notable exit was Biogen, an estimated $32.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Origin Asset Management opened a new position in Dr. Reddy's Laboratories worth $38.2M.
- Origin Asset Management's largest Q3 2015 buy was Dr. Reddy's Laboratories: 2,987,340 shares worth $38.2M.
- Origin Asset Management added most to Cognizant in Q3 2015, an estimated $30.6M increase.
- Origin Asset Management's biggest Q3 2015 reduction was TSMC, cutting an estimated $19.9M.
- Origin Asset Management fully exited Biogen in Q3 2015, selling an estimated $32.5M.
- Origin Asset Management's ten largest holdings make up 32% of its $1.21B portfolio in Q3 2015.
- Origin Asset Management opened 22 new positions and closed 24 in Q3 2015.
- Origin Asset Management's portfolio value fell 12% quarter-over-quarter to $1.21B.
Based on Origin Asset Management's 13F filing for Q3 2015, filed 9 Nov 2015.